Secondary Logo

Share this article on:

Choopanya Kachit; Des Jarlais, Don C.; Vanichseni, Suphak; Kitayaporn, Dwip; Mock, Philip A.; Raktham, Suwanee; Hireanras, Krit; Heyward, William L.; Sujarita, Sathit; Mastro, Timothy D.
JAIDS Journal of Acquired Immune Deficiency Syndromes: January 1st, 2002
Article: PDF Only

Objective: To assess potential multiple relationships between incarceration and HIV infection among injecting drug users (IDUs) in Bangkok. Previous cross-sectional studies have shown strong relationships between incarceration and HIV infection but have not been able to assess potential causal pathways.Methods: Injection drug users seen at methadone treatment programs in Bangkok were screened during 1995 to 1996 for enrollment into the study. With informed consent, 1,209 seronegative IDUs were enrolled in a cohort study to determine HIV incidence and identify factors associated with incident infections. Follow-up visits were conducted every 4 months, with HIV testing and assessment of risk behaviors.Results: Overall incidence rate was 5.8 per 100 person-years (95% confidence interval [CI], 4.8-6.8) of follow-up. A four-step “injection risk” scale was constructed that included less frequent than daily injection, daily injection, daily injection with reported sharing of injection equipment, and injection while incarcerated. This scale was strongly related to HIV incidence, with incidence approximately doubling for each step in the scale. Incidence rate for follow-up periods that contained drug injection while incarcerated was 35/100 person-years at risk. In multivariate analyses, incarceration was related to incident HIV infection in multiple ways: previous incarceration and recent incarceration without drug injection, and the injection risk scale were all independently predictors of incident HIV infection.Conclusions: Incarceration is related to incident HIV infection through multiple pathways. Previous incarcerations are likely to serve as markers for unmeasured highrisk behaviors, and it is also highly likely that HIV is transmitted during periods of incarceration. Programs to reduce HIV transmission in jails and prisons, including drug abuse treatment of inmates and programs to reduce the likelihood of incarceration of IDUs, are needed urgently. Given the current diffusion of injecting drug use, of HIV infection among drug injectors, and of the common policy of incarcerating drug users, it is very likely that the problem of HIV transmission in jails and prisons is increasing in many countries throughout the world.

Preliminary versions of these analyses were presented in part at the XII World AIDS Conference, Geneva, Switzerland, June 1998, and the Fifth Conference on AIDS in Asia and the Pacific, Kuala Lumpur, Malaysia, October 1999.

Address correspondence and reprint requests to Don C. Des Jarlais, Beth Israel Medical Center/CDI, 1st Avenue and 16th Street, New York City, NY 10003 U.S.A.; e-mail: Manuscript received May 29, 2001; accepted September 12, 2001.

© 2002 Lippincott Williams & Wilkins, Inc.